recurrent prostate cancer / metastatic prostate cancer / residual disease / castration-resistant prostate cancer / clinically significant disease / distant metastasis / metastatic disease / metastatic bone disease / Introduction Prostate cancer / Prostate Cancer / tumor / cancer / tumors / aggressive lymph node metastasis / bone metastases / bone metastasis / localized prostate cancer / clinically localized cancer / metastases / single lymph node metastasis / primary prostate cancer / high-grade cancers / prostate bone metastasis / metastasis / indolent disease / only prostate cancer / bone metabolic disorders / cancers / advanced prostate cancer / disseminated lymph node metastasis / disease / localized cancer / This disease / lung cancer / extra-periprostatic metastasis / prostate cancer bone metastasis / direct cancer therapeutics targeting bone metastasis / carcinomas / standardized cancer / /
Helen Diller Family Comprehensive Cancer Center / University of California / San Francisco / National Institute of Health / San Francisco Veterans Affairs Medical Center / US Food and Drug Administration / /
Person
Helen Diller / Carina Mari Aparici / Youngho Seo / / /
Position
Author / representative / Public Access Author / /